Recent studies investigating glioblastoma have shown that chemotherapy with temozolomide (TMZ) induces an upregulation of proteases such as ADAM8, ADAM10, and ADAM17, which are likely involved in the cleavage of immunomodulatory molecules like PD-L1. This evidence concerns the gene CD274 and glioblastoma.